LY333531, a PKCβ inhibitor, attenuates glomerular endothelial cell apoptosis in the early stage of mouse diabetic nephropathy via down-regulating swiprosin-1.
about
LY333531, a PKCβ inhibitor, attenuates glomerular endothelial cell apoptosis in the early stage of mouse diabetic nephropathy via down-regulating swiprosin-1.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
LY333531, a PKCβ inhibitor, at ...... a down-regulating swiprosin-1.
@en
LY333531, a PKCβ inhibitor, at ...... a down-regulating swiprosin-1.
@nl
type
label
LY333531, a PKCβ inhibitor, at ...... a down-regulating swiprosin-1.
@en
LY333531, a PKCβ inhibitor, at ...... a down-regulating swiprosin-1.
@nl
prefLabel
LY333531, a PKCβ inhibitor, at ...... a down-regulating swiprosin-1.
@en
LY333531, a PKCβ inhibitor, at ...... a down-regulating swiprosin-1.
@nl
P2093
P2860
P356
P1476
LY333531, a PKCβ inhibitor, at ...... a down-regulating swiprosin-1.
@en
P2093
Ding-Feng Su
Li-Chao Zhang
Ling-Chang Tong
Rong-Mei Wang
Wei-Ye Liu
P2860
P2888
P304
P356
10.1038/APS.2016.172
P577
2017-04-17T00:00:00Z